{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:41:34Z","timestamp":1791348094172,"version":"4.3.1"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T00:00:00Z","timestamp":1359590400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0054578","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T22:03:23Z","timestamp":1359669803000},"page":"e54578","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":214,"title":["Nanoceria: A Rare-Earth Nanoparticle as a Novel Anti-Angiogenic Therapeutic Agent in Ovarian Cancer"],"prefix":"10.1371","volume":"8","author":[{"given":"Shailendra","family":"Giri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Karakoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rondell P.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacie L.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipta","family":"Seal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramandeep","family":"Rattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viji","family":"Shridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,1,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4757-3587-1_3","article-title":"Early detection of ovarian cancer: promise and reality","volume":"107","author":"RC Bast Jr","year":"2002","journal-title":"Cancer Treat Res"},{"key":"ref2","first-page":"305","article-title":"Prognostic factors in ovarian cancer","volume":"25","author":"ML Friedlander","year":"1998","journal-title":"Semin Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/nnano.2006.91","article-title":"Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides","volume":"1","author":"J Chen","year":"2006","journal-title":"Nat Nanotechnol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.biomaterials.2006.11.036","article-title":"Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons","volume":"28","author":"M Das","year":"2007","journal-title":"Biomaterials"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1021\/nl052024f","article-title":"Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage","volume":"5","author":"RW Tarnuzzer","year":"2005","journal-title":"Nano Lett"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1016\/j.biomaterials.2007.07.029","article-title":"Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential","volume":"28","author":"S Patil","year":"2007","journal-title":"Biomaterials"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"P Carmeliet","year":"2000","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrc905","article-title":"Clinical translation of angiogenesis inhibitors","volume":"2","author":"R Kerbel","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/S0959-8049(96)00387-5","article-title":"Vascular endothelial growth factor","volume":"32A","author":"N Ferrara","year":"1996","journal-title":"Eur J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0140-6736(92)93217-B","article-title":"Relation of neovascularisation to metastasis of non-small-cell lung cancer","volume":"340","author":"P Macchiarini","year":"1992","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A","article-title":"Vascular endothelial growth factor expression in early stage ovarian carcinoma","volume":"80","author":"PJ Paley","year":"1997","journal-title":"Cancer"},{"key":"ref12","first-page":"401","article-title":"Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma","volume":"143","author":"N Weidner","year":"1993","journal-title":"Am J Pathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199101033240101","article-title":"Tumor angiogenesis and metastasis\u2013correlation in invasive breast carcinoma","volume":"324","author":"N Weidner","year":"1991","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2007.11.5345","article-title":"Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study","volume":"25","author":"RA Burger","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"17232","DOI":"10.1021\/jp076164k","article-title":"Direct Synthesis of Nanoceria in Aqueous Polyhydroxyl Solutions","volume":"111","author":"AS Karakoti","year":"2007","journal-title":"Journal of Physical Chemistry C"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11837-008-0029-8","article-title":"Nanoceria as antioxidant: Synthesis and biomedical applications","volume":"60","author":"AS Karakoti","year":"2008","journal-title":"Jom"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"14144","DOI":"10.1021\/ja9051087","article-title":"PEGylated nanoceria as radical scavenger with tunable redox chemistry","volume":"131","author":"AS Karakoti","year":"2009","journal-title":"J Am Chem Soc"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1158\/0008-5472.CAN-05-3582","article-title":"HSulf-1 inhibits angiogenesis and tumorigenesis in vivo","volume":"66","author":"K Narita","year":"2006","journal-title":"Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1582-4934.2009.00954.x","article-title":"Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner","volume":"15","author":"R Rattan","year":"2011","journal-title":"J Cell Mol Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"39582","DOI":"10.1074\/jbc.M507443200","article-title":"5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase","volume":"280","author":"R Rattan","year":"2005","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/j.1471-4159.2008.05279.x","article-title":"The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe disease","volume":"105","author":"S Giri","year":"2008","journal-title":"J Neurochem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1194\/jlr.M600084-JLR200","article-title":"Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death","volume":"47","author":"S Giri","year":"2006","journal-title":"J Lipid Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1523-1747.1999.00708.x","article-title":"Thymosin beta4 accelerates wound healing","volume":"113","author":"KM Malinda","year":"1999","journal-title":"J Invest Dermatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1593\/neo.11148","article-title":"Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo","volume":"13","author":"R Rattan","year":"2011","journal-title":"Neoplasia"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Hirst SM, Karakoti A, Singh S, Self W, Tyler R, <etal>et al<\/etal>.. (2011) Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice. Environmental toxicology.","DOI":"10.1002\/tox.20704"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Deshpande S, Patil S, Kuchibhatla S, Seal S (2005) Size dependency variation in lattice parameter and valency states in nanocrystalline cerium oxide. Applied Physics Letters 87.","DOI":"10.1063\/1.2061873"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/carcin\/bgn167","article-title":"Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells","volume":"29","author":"DW Chan","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.freeradbiomed.2006.08.003","article-title":"Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells","volume":"41","author":"LZ Liu","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"10823","DOI":"10.1158\/0008-5472.CAN-07-0783","article-title":"Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor","volume":"67","author":"C Xia","year":"2007","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s12094-009-0406-y","article-title":"Angiogenesis and ovarian cancer","volume":"11","author":"C Gomez-Raposo","year":"2009","journal-title":"Clin Transl Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1517\/14656560903120907","article-title":"Antiangiogenic drugs in ovarian cancer","volume":"10","author":"M Markman","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ygyno.2010.08.014","article-title":"Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival","volume":"119","author":"F Lose","year":"2010","journal-title":"Gynecol Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0002-9440(10)65669-6","article-title":"Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization","volume":"153","author":"S Mesiano","year":"1998","journal-title":"Am J Pathol"},{"key":"ref34","first-page":"360","article-title":"Vascular endothelial growth factor serum concentrations in ovarian cancer","volume":"92","author":"C Tempfer","year":"1998","journal-title":"Obstet Gynecol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3727\/096504001108747567","article-title":"Interleukin 8: an autocrine growth factor for human ovarian cancer","volume":"12","author":"L Xu","year":"2000","journal-title":"Oncol Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pharmthera.2010.07.007","article-title":"Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise","volume":"128","author":"DJ Bharali","year":"2010","journal-title":"Pharmacol Ther"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2174\/156652410792630634","article-title":"From nanotechnology to nanomedicine: applications to cancer research","volume":"10","author":"R Seigneuric","year":"2010","journal-title":"Curr Mol Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nano.2008.10.003","article-title":"Protection from radiation-induced pneumonitis using cerium oxide nanoparticles","volume":"5","author":"J Colon","year":"2009","journal-title":"Nanomedicine"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.nano.2010.01.010","article-title":"Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2","volume":"6","author":"J Colon","year":"2010","journal-title":"Nanomedicine"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/IJN.S15308","article-title":"The protective effects of cerium oxide nanoparticles against hepatic oxidative damage induced by monocrotaline","volume":"6","author":"KA Amin","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Alili L, Sack M, Karakoti AS, Teuber S, Puschmann K, et al. (2011 ) Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions. Biomaterials.","DOI":"10.1016\/j.biomaterials.2010.12.056"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/toxsci\/kfq137","article-title":"Brain distribution and toxicological evaluation of a systemically delivered engineered nanoscale ceria","volume":"116","author":"SS Hardas","year":"2010","journal-title":"Toxicol Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"J Folkman","year":"1971","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"re21","DOI":"10.1126\/stke.2001.112.re21","article-title":"VEGF receptor signal transduction","volume":"2001","author":"T Matsumoto","year":"2001","journal-title":"Sci STKE"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/emboj\/20.11.2768","article-title":"A single autophosphorylation site on KDR\/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells","volume":"20","author":"T Takahashi","year":"2001","journal-title":"Embo J"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"32521","DOI":"10.1074\/jbc.272.51.32521","article-title":"The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells","volume":"272","author":"J Kroll","year":"1997","journal-title":"J Biol Chem"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.canlet.2008.02.044","article-title":"Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy","volume":"266","author":"M Ushio-Fukai","year":"2008","journal-title":"Cancer Lett"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Burger RA (2011) Overview of anti-angiogenic agents in development for ovarian cancer. Gynecol Oncol.","DOI":"10.1016\/j.ygyno.2010.11.035"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1200\/JCO.2007.12.0782","article-title":"Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer","volume":"25","author":"SA Cannistra","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1200\/JCO.2007.12.1939","article-title":"Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia","volume":"26","author":"AA Garcia","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1200\/JCO.2009.22.7900","article-title":"Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors","volume":"28","author":"RT Penson","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ygyno.2010.10.002","article-title":"Bladder perforation in a patient with recurrent epithelial ovarian cancer after treatment with bevacizumab","volume":"120","author":"N Bansal","year":"2011","journal-title":"Gynecol Oncol"},{"key":"ref53","first-page":"4743","article-title":"Wound complications after bevacizumab treatment in patients operated on for ovarian cancer","volume":"30","author":"M Koskas","year":"2010","journal-title":"Anticancer Res"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Lecarpentier E, Ouaffi L, Mir O, Berveiller P, Maurel M, <etal>et al<\/etal>.. (2010) Bevacizumab-induced small bowel perforation in a patient with breast cancer without intraabdominal metastases. Invest New Drugs.","DOI":"10.1007\/s10637-010-9505-4"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ygyno.2010.02.021","article-title":"Bevacizumab toxicities and their management in ovarian cancer","volume":"117","author":"LM Randall","year":"2010","journal-title":"Gynecol Oncol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0054578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T03:22:09Z","timestamp":1644204129000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0054578"}},"subtitle":[],"editor":[{"given":"Surinder K.","family":"Batra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,31]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0054578","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,31]]}}}